An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

Inclusion Criteria

• Advanced Non Small Cell Lung Cancer (NSCLC)
• Eastern Cooperative Oncology Group (ECOG) Performance status of ≤ 1
• Life expectancy of at least 3 months from most recent chemotherapy or immunotherapy treatment
• Must have at least 1 lesion with measurable disease

Exclusion Criteria

• Subjects with certain mutations that have not been treated with a targeted therapy prior to enrollment
• Subjects who need daily oxygen therapy
• People with autoimmune disease Other protocol defined inclusion/exclusion criteria could apply